MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas
Abstract Background Constitutional BRCA1 epimutations (promoter hypermethylation) are associated with an elevated risk of triple-negative breast cancer and high-grade serous ovarian cancer. While MGMT epimutations are frequent in colon cancer, glioblastoma, and B-cell lymphoma, it remains unknown wh...
Saved in:
| Main Authors: | Oleksii Nikolaienko, Garnet L. Anderson, Rowan T. Chlebowski, Su Yon Jung, Holly R. Harris, Stian Knappskog, Per E. Lønning |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Clinical Epigenetics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13148-025-01835-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer
by: Mathias Schwartz, et al.
Published: (2025-06-01) -
IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study
by: Moez Eid, et al.
Published: (2025-05-01) -
Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway
by: Xiaohang Cui, et al.
Published: (2025-07-01) -
The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI‐derived and clinical features, predict adult primary glioblastoma survival
by: Chang Shu, et al.
Published: (2018-08-01) -
The impact of the subventricular zone invasion types and MGMT methylation status on tumor recurrence and prognosis in glioblastoma
by: Zhiying Shao, et al.
Published: (2024-12-01)